Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC25A1 | P53007 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.57 |
| ▸ | AKR1C2 | P52895 | 4/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.57 |
| ▸ | AKR1C4 | P17516 | 2/20 | 0.57 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 0.57 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.57 |
| ▸ | MYC | P01106 | 1/20 | 0.54 |
| ▸ | FABP3 | P05413 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.53 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.52 |
| ▸ | TTR | P02766 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16489006 | 0.83 | SLC25A1 (0.65) | SLC25A1MEN1KMT2AAKR1C3AKR1C2 | |
| SCHEMBL29532900 | 0.81 | AKR1C3 (0.67) | SLC25A1MEN1KMT2AAKR1C3AKR1C2 | |
| SCHEMBL16489005 | 0.81 | AKR1C3 (0.67) | SLC25A1MEN1KMT2AAKR1C3AKR1C2 | |
| SCHEMBL2112961 | 0.81 | AKR1C3 (0.67) | SLC25A1MEN1KMT2AAKR1C3AKR1C2 | |
| SCHEMBL16489011 | 0.81 | MYC (0.60) | SLC25A1MEN1KMT2AAKR1C3AKR1C2 | |
| SCHEMBL453183 | 0.81 | AKR1C3 (0.68) | MEN1KMT2AAKR1C3AKR1C2AKR1B1 | |
| SCHEMBL6141546 | 0.79 | PBRM1 (0.68) | MEN1KMT2AAKR1C3AKR1C2AKR1B1 | |
| SCHEMBL23567 | 0.78 | AKR1C3 (0.67) | MEN1KMT2AAKR1C3AKR1C2AKR1B1 | |
| SCHEMBL29785279 | 0.78 | AKR1C3 (0.67) | MEN1KMT2AAKR1C3AKR1C2AKR1B1 | |
| SCHEMBL29377063 | 0.78 | AKR1C3 (0.67) | MEN1KMT2AAKR1C3AKR1C2AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150051286-A1 | ANTHRANILIC ACID DERIVATIVES: NOVEL INHIBITORS OF ADVANCED GLYCATION END-PRODUCTS (AGES) FORMATION | CHOUDHARY MUHAMMAD IQBAL (PK) | 2015-02-19 | — | — | US | disclosed |
| US-20150051286-A1 | ANTHRANILIC ACID DERIVATIVES: NOVEL INHIBITORS OF ADVANCED GLYCATION END-PRODUCTS (AGES) FORMATION | CHOUDHARY MUHAMMAD IQBAL (PK) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051286-A1 | ANTHRANILIC ACID DERIVATIVES: NOVEL INHIBITORS OF ADVANCED GLYCATION END-PRODUCTS (AGES) FORMATION | AGER, NFKBIA, DNPEP | SLC25A1 2255/4885MEN1 3683/4885KMT2A 2971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.